🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
CTM
CytomX Therapeutics Inc
AVG HISTORICAL GAP
+10.48%
MAX GAP RECORD
+104.74%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $CTMX
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$CTMX
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
-1.48%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+1.00%
|
| Mar 16, 2026 Earnings Release 2026-03-16 (BEFORE OPEN) |
+47.86%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-9.31%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-2.38%
|
| May 12, 2025 Earnings Release 2025-05-12 (BEFORE OPEN) |
+104.74%
|
| Mar 06, 2025 Earnings Release 2025-03-06 (AFTER CLOSE) |
+15.07%
|
| Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE) |
+15.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
18.2%
Bullish Gaps (4)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗